Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Music icon Barry Manilow today revealed his long struggle to manage a serious heart disease called atrial fibrillation (AFib). He has joined with Sanofi US to kick-off Get Back in Rhythm™, a national education campaign to raise awareness about AFib, and to encourage people to learn more about all the risks of AFib and the importance of keeping the heart in rhythm.
Today, approximately 2.5 million Americans have AFib and that number is expected to grow to 12 million by 2050. A serious heart disease that causes the heart to race and beat out of rhythm, AFib can lead to permanent heart damage, heart attack, heart failure, stroke and death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51813-get-back-in-rhythm-barry-manilow-afib-awareness
A new national survey shows most preteens and teens engage in day-to-day activities that may put them at risk of contracting meningococcal meningitis, a rare, but serious bacterial infection that can cause meningitis and take the life of an otherwise healthy child in just a single day. The National Association of School Nurses (NASN), in collaboration with Sanofi Pasteur, conducted the survey as part of its Voices of Meningitis back-to-school vaccination awareness initiative.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/voicesofmeningitis/50125/
